Targeting macrophage anti-tumor activity to suppress melanoma progression

Huafeng Wang1, Lijuan Zhang1,2, Luhong Yang1

  • 1Modern College of Arts and Science, or School of Life Science, Shanxi Normal University, Linfen, China.

Oncotarget
|January 7, 2017
PubMed

Insights

Macrophages are key immune cells in fighting melanoma. Targeting their anti-tumor functions offers a promising strategy for melanoma inhibition, potentially combined with other therapies.

Area of Science:

  • Immunology and Cancer Biology
  • Focuses on the dual role of macrophages in innate and adaptive immunity, specifically within the context of melanoma.

Background:

  • Malignant melanoma is a highly lethal cancer due to its metastatic potential and resistance to conventional treatments.
  • Developing effective immunotherapies for metastatic melanoma has been a long-standing challenge in oncology.

Purpose of the Study:

  • To review the anti-tumor activities of macrophages in melanoma.
  • To explore the potential of targeting macrophages as a therapeutic strategy for melanoma treatment.

Main Methods:

  • This is a review article, synthesizing existing research on macrophage functions in melanoma.
  • Analysis of intercellular signaling pathways that influence macrophage plasticity and tumor interaction.

Main Results:

  • Macrophages exhibit plasticity, with the potential to promote tumor survival through re-education.
  • Despite plasticity, macrophages possess inherent anti-tumor activities that can be harnessed.

Conclusions:

  • Targeting the anti-tumor functions of macrophages is a promising strategy for melanoma inhibition.
  • Combining macrophage-activating therapies with conventional treatments like surgery, chemotherapy, and radiotherapy may offer a comprehensive anti-melanoma approach.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K